Kon-Kiki Pharma ApS: Financial statements 2023
CVR: 43311824
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Kon-Kiki Pharma ApS (CVR 43311824) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,690,401 and a net result of DKK 603,209. Equity in the 2023 report amounted to DKK 706,272. The solvency ratio was 73.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,690,401
- Profit/Loss
- DKK 603,209
- Equity
- DKK 706,272
- Total Assets
- DKK 965,032
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Kon-Kiki Pharma ApS has published its interim report for the period June 7, 2022 to December 31, 2022.
About Kon-Kiki Pharma ApS
Kon-Kiki Pharma ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Kiki Atting Andersen. The company is owned by Kiki Andersen Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,539,454 and a net result of DKK 419,959 compared with DKK 503,219 the year before. Equity in the 2025 report amounted to DKK 460,450.